Introduction

Being geographically close to India, Bangladesh is concerned about the alarming rise in COVID-19-related black fungus infections in India, which have a high fatality rate of nearly 50%. The death rate for mucormycosis, sometimes known as a black fungus infection, ranges from 46 to 96%, depending on the patient's underlying health.1 The large second wave of the COVID-19 epidemic has presented a challenge for the Indian healthcare system from this life-threatening new enemy.2 The fungus family Mucorales causes mucormycosis, which affects numerous bodily organs. This fungal opportunistic illness spreads quickly. Now, this unusual fungus has been infecting covid patients in India at higher rates than before.3

In India, the frequency of this black fungus infection among covid-19 and post-covid-19 patients is now on the rise.4 India reported 28,252 mucormycosis cases as of June 8, 2021. They had a history of covid-19 in 86.0% of them and diabetes in 62.3% of them. The true prevalence is thus expected to be substantially greater than the recorded instances, according to the health experts.5 Almost 70 times more cases of black fungus infection have been documented in India than in the rest of the world.6

Need of the Study

"Here, we already see two to three instances every week. The pandemic itself is a nightmare "The information was provided by her. Dr. Raghuraj Hegde, an eye surgeon in Bangalore in southern India, has a similar tale. In the previous two weeks, he has treated 19 patients with mucormycosis, most of them were young. Several of them were too ill for surgery, as you said. The severity and prevalence of this fungal illness during the second wave, as compared to a few instances during the first wave last year, have startled doctors, they add. Dr. Nair claims that over the previous two years, he has only encountered 10 instances in Bombay.7

Modern black fungus infections linked to COVID-19 are primarily of the rhino orbital cerebral kind, which clinically manifests around the nose, eye, and brain. Corticosteroid medication is presently recommended as a risk factor for black fungus infection in the treatment of COVID-19 patients with diabetes mellitus. According to a research, patients with COVID-19 were more likely to develop pulmonary mucormycosis because of their immunocompromised status. The pathogenesis of the black fungus comprises vascular thrombosis and subsequent tissue necrosis, both of which result in death rates of about 54%.

The best way to avoid contracting black fungus at COVID19 is to stay away from the risk factors. There is presently no vaccine for black fungus, even though COVID-19 immunisation has begun. Hence, to treat COVID-19-induced illness, early identification and therapy are crucial.8

Objectives of the Study

Research Methodology

Result

Frequency and Percentage distribution of staff nurse according to socio demographic variables.

Under pre-test the Mean of the scores was 8.3 (55.33%) under the Post- test the Mean was observed as 12.2 (81.33%).

Figure 1

Pyramid diagram showing the percentage distribution of mean percentage difference between pre and post -test knowledge

Conclusion

There is presently no vaccine for black fungus, even though COVID-19 immunisation has begun. Hence, to treat COVID-19-induced illness, early identification and therapy are crucial.

Source of Funding

None.

Conflict of Interest

None.